Sacituzumab Tirumotecan in Combination With Anlotinib in Previously Treated Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Clinical trial NCT07501169 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07501169
- Sponsor
- Sichuan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2027-08-31
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.